Rebecca GAICD Wilson
About
Rebecca GAICD Wilson is from Melbourne, Victoria, Australia. Rebecca is currently Chairperson at LBT Innovations Ltd, located in Adelaide, South Australia, Australia. Rebecca also works as Non-Executive Director at Ateria Health, a job Rebecca has held since Aug 2021. Another title Rebecca currently holds is Chairperson at Alcidion Group Limited (ASX:ALC).
You can find Rebecca GAICD Wilson's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Rebecca GAICD Wilson's current jobs
LBT Innovations is an ASX listed company with a history of developing world leading products in microbiology automation. Its first product, MicroStreak®, was a global first in the automation of culture plate specimen processing. The Company’s second product, the Automated Plate Assessment System (APAS® Independence) uses LBT’s intelligent imaging and machine learning software to automate the imaging, analysis and interpretation of culture plates following incubation. The technology remains the only US FDA-cleared artificial intelligence technology for automated culture plate reading and is being commercialised through LBT’s wholly owned subsidiary Clever Culture Systems AG (CCS). Thermo Fisher Scientific, Inc is exclusive distributor of the APAS® Independence in the United States and selected countries in Europe.
Rebecca joined the board of Alcidion (ASX ALC) as a Non-Executive Director in 2017 before her appointment as Chairperson in 2019. Alcidion has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide. Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes. Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 400 hospitals and 87 healthcare organisations, with further geographical expansion planned. With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.